Hims & Hers Health, Inc. Reports Second Quarter 2026 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/7/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Hims & Hers Health, Inc. (HIMS) Misses Q2 EPS by 32c, Beats on Revenue; Offers FY26 Revenue Guidance
August 10, 2026 4:09 PM EDTHims & Hers Health, Inc. (NYSE: HIMS) reported Q2 EPS of ($0.37), $0.32 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $753 million versus the consensus estimate of $691.65 million.
GUIDANCE:
Hims & Hers Health, Inc. sees FY2026 revenue of $3.1-3.3... More
